Article Details
Retrieved on: 2021-10-06 16:52:42
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Bridgewest Group has launched BioCina, a microbial therapy and mRNA-based manufacturer operating from a former Pfizer facility in Adelaide, Australia.
Article found on: bioprocessintl.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here